Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate whether vepoloxamer can provide a blood chemical marker and functional benefit to damaged heart muscle cells. This will be evaluated by measurement of blood-ba...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Mast Therapeutics, Inc.
NCT06148935 · Chronic Heart Failure With Reduced Ejection Fraction
NCT04471129 · Chronic Heart Failure
NCT07434193 · Chronic Heart Failure
NCT06019169 · Chronic Heart Failure
NCT07325942 · Chronic Heart Failure
Research Center
Detroit, Michigan
Research Center
Tupelo, Mississippi
Research Center
Cardiff, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions